Mitochondrial dynamics in type 2 diabetes: Pathophysiological implications

Redox Biology

Volumn 11, Issue , 2017, Pages 637-645

  Rovira Llopis, Susana ^a   Bañuls, Celia ^a   Diaz Morales, Noelia ^a   Hernandez Mijares, Antonio ^a,b   Rocha, Milagros ^a,b   Victor, Victor M ^a,b  

^a HOSPITAL UNIVERSITARIO DR PESET   (Spain)

^b UNIVERSITY OF VALENCIA   (Spain)

Author keywords

Mitochondrial dynamics; Oxidative stress; Redox biology; Type 2 diabetes

Indexed keywords

15 OXOSPIRAMILACTONE; ANTINEOPLASTIC AGENT; ANTIOXIDANT; DYNASORE; ENZYME INHIBITOR; METFORMIN; MITOCHONDRIAL DIVISION INHIBITOR 1; P 110; REACTIVE OXYGEN METABOLITE; RESVERATROL; UNCLASSIFIED DRUG; ADENOSINE TRIPHOSPHATE; MITOCHONDRIAL PROTEIN;

CALORIC RESTRICTION; EXERCISE; HUMAN; INSULIN RESISTANCE; MITOCHONDRIAL DYNAMICS; MITOCHONDRIAL FISSION; MITOCHONDRIAL FUSION; MITOPHAGY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXIDATIVE STRESS; PANCREAS ISLET BETA CELL; PATHOPHYSIOLOGY; REVIEW; GENETICS; METABOLISM; MITOCHONDRION; PATHOLOGY; PHYSIOLOGY;

ADENOSINE TRIPHOSPHATE; DIABETES MELLITUS, TYPE 2; HUMANS; MITOCHONDRIA; MITOCHONDRIAL DEGRADATION; MITOCHONDRIAL DYNAMICS; MITOCHONDRIAL PROTEINS; REACTIVE OXYGEN SPECIES;

EID: 85010332704     PISSN: 22132317     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.redox.2017.01.013     Document Type: Review

References (92)

1. [1] Szendroedi, J., Phielix, E., Roden, M., The role of mitochondria in insulin resistance and type 2 diabetes mellitus. Nat. Rev. Endocrinol. 8:2 (2011), 92–103, 10.1038/nrendo.2011.138.
2. [2] Petersen, K.F., Befroy, D., Dufour, S., Dziura, J., Ariyan, C., Rothman, D.L., DiPietro, L., Cline, G.W., Shulman, G.I., Mitochondrial dysfunction in the elderly: possible role in insulin resistance. Science 300:5622 (2003), 1140–1142, 10.1126/science.1082889.
3. [3] Brownlee, M., Biochemistry and molecular cell biology of diabetic complications. Nature 414:6865 (2001), 813–820, 10.1038/414813a.
4. [4] Twig, G., Elorza, A., Molina, A.J., Mohamed, H., Wikstrom, J.D., Walzer, G., Stiles, L., Haigh, S.E., Katz, S., Las, G., Alroy, J., Wu, M., Py, B.F., Yuan, J., Deeney, J.T., Corkey, B.E., Shirihai, O.S., Fission and selective fusion govern mitochondrial segregation and elimination by autophagy. EMBO J. 27:2 (2008), 433–446, 10.1038/sj.emboj.7601963.
5. [5] van der Bliek, A.M., Shen, Q., Kawajiri, S., Mechanisms of mitochondrial fission and fusion. Cold Spring Harb. Perspect. Biol., 5(6), 2013, 10.1101/cshperspect.a011072.
6. [6] Ding, W.X., Yin, X.M., Mitophagy: mechanisms, pathophysiological roles, and analysis. Biol. Chem. 393:7 (2012), 547–564, 10.1515/hsz-2012-0119.
7. [7] Lemasters, J.J., Variants of mitochondrial autophagy: Types 1 and 2 mitophagy and micromitophagy (Type 3). Redox Biol. 2 (2014), 749–754, 10.1016/j.redox.2014.06.004 eCollection 2014.
8. [8] Youle, R.J., Narendra, D.P., Mechanisms of mitophagy. Nat. Rev. Mol. Cell Biol. 12:1 (2011), 9–14, 10.1038/nrm3028.
9. [9] Kiritoshi, S., Nishikawa, T., Sonoda, K., Kukidome, D., Senokuchi, T., Matsuo, T., Matsumura, T., Tokunaga, H., Brownlee, M., Araki, E., Reactive oxygen species from mitochondria induce cyclooxygenase-2 gene expression in human mesangial cells: potential role in diabetic nephropathy. Diabetes 52:10 (2003), 2570–2577, 10.2337/diabetes.52.10.2570.
10. [10] Sharma, K., Mitochondrial hormesis and diabetic complications. Diabetes 64:3 (2015), 663–672, 10.2337/db14-0874.
11. [11] Ni, H.M., Williams, J.A., Ding, W.X., Mitochondrial dynamics and mitochondrial quality control. Redox Biol. 4 (2015), 6–13, 10.1016/j.redox.2014.11.006.
12. [12] Westermann, B., Mitochondrial fusion and fission in cell life and death. Nat. Rev. Mol. Cell Biol. 11:12 (2010), 872–884, 10.1038/nrm3013.
13. [13] Youle, R.J., van der Bliek, A.M., Mitochondrial fission, fusion, and stress. Science 337:6098 (2012), 1062–1065, 10.1126/science.1219855.
14. [14] Galloway, C.A., Yoon, Y., Mitochondrial morphology in metabolic diseases. Antioxid. Redox Signal. 19:4 (2013), 415–430, 10.1089/ars.2012.4779.
15. [15] Detmer, S.A., Chan, D.C., Complementation between mouse Mfn1 and Mfn2 protects mitochondrial fusion defects caused by CMT2A disease mutations. J. Cell Biol. 176:4 (2007), 405–414, 10.1083/jcb.200611080.
16. [16] de Brito, O.M., Scorrano, L., Mitofusin 2 tethers endoplasmic reticulum to mitochondria. Nature 456:7222 (2008), 605–610, 10.1038/nature07534.
17. [17] Otera, H., Mihara, K., Molecular mechanisms and physiologic functions of mitochondrial dynamics. J. Biochem. 149:3 (2011), 241–251, 10.1093/jb/mvr002.
18. [18] Yoon, Y., Galloway, C.A., Jhun, B.S., Yu, T., Mitochondrial dynamics in diabetes. Antioxid. Redox Signal. 14:3 (2011), 439–457, 10.1089/ars.2010.3286.
19. [19] Loson, O.C., Song, Z., Chen, H., Chan, D.C., Fis1, Mff, MiD49, and MiD51 mediate Drp1 recruitment in mitochondrial fission. Mol. Biol. Cell 24:5 (2013), 659–667, 10.1091/mbc.E12-10-0721.
20. [20] Liesa, M., Shirihai, O.S., Mitochondrial dynamics in the regulation of nutrient utilization and energy expenditure. Cell Metab. 17:4 (2013), 491–506, 10.1016/j.cmet.2013.03.002.
21. [21] Wai, T., Langer, T., Mitochondrial Dynamics and Metabolic Regulation. Trends Endocrino. Metab. 27:2 (2016), 105–117, 10.1016/j.tem.2015.12.001.
22. [22] Quirós, P.M., Ramsay, A.J., Sala, D., Fernández-Vizarra, E., Rodríguez, F., Peinado, J.R., Fernández-García, M.S., Vega, J.A., Enríquez, J.A., Zorzano, A., López-Otín, C., Loss of mitochondrial protease OMA1 alters processing of the GTPase OPA1 and causes obesity and defective thermogenesis in mice. EMBO J. 31:9 (2012), 2117–2133, 10.1038/emboj.2012.70.
23. [23] Sebastián, D., Hernández-Alvarez, M.I., Segalés, J., Sorianello, E., Muñoz, J.P., Sala, D., Waget, A., Liesa, M., Paz, J.C., Gopalacharyulu, P., Orešič, M., Pich, S., Burcelin, R., Palacín, M., Zorzano, A., Mitofusin 2 (Mfn2) links mitochondrial and endoplasmic reticulum function with insulin signaling and is essential for normal glucose homeostasis. Proc Natl. Acad. Sci. USA 109:14 (2012), 5523–5528, 10.1073/pnas.1108220109.
24. [24] Kulkarni, S.S., Joffraud, M., Boutant, M., Ratajczak, J., Gao, A.W., Maclachlan, C., Hernandez-Alvarez, M.I., Raymond, F., Metairon, S., Descombes, P., Houtkooper, R.H., Zorzano, A., Cantó C6. Mfn1 Deficiency in the liver protects against diet-induced insulin resistance and enhances the hypoglycemic effect of metformin. Diabetes, 2016, 10.2337/db15-1725.
25. [25] Wang, L., Ishihara, T., Ibayashi, Y., Tatsushima, K., Setoyama, D., Hanada, Y., Takeichi, Y., Sakamoto, S., Yokota, S., Mihara, K., Kang, D., Ishihara, N., Takayanagi, R., Nomura, M., Disruption of mitochondrial fission in the liver protects mice from diet-induced obesity and metabolic deterioration. Diabetologia 58:10 (2015), 2371–2380, 10.1007/s00125-015-3704-7.
26. [26] Mizushima, N., Komatsu, M., Autophagy: renovation of cells and tissues. Cell 147:4 (2011), 728–741, 10.1016/j.cell.2011.10.026.
27. [27] Dorn, G.W. 2nd, Kitsis, R.N., The mitochondrial dynamism-mitophagy-cell death interactome: multiple roles performed by members of a mitochondrial molecular ensemble. Circ. Res. 116:1 (2015), 167–182, 10.1161/CIRCRESAHA.116.303554.
28. [28] Stotland, A., Gottlieb, R.A., Mitochondrial quality control: Easy come, easy go. Biochim. Biophys. Acta 1853:10 Pt B (2015), 2802–2811, 10.1016/j.bbamcr.2014.12.041.
29. [29] Geisler, S., Holmström, K.M., Skujat, D., Fiesel, F.C., Rothfuss, O.C., Kahle, P.J., Springer, W., PINK1/Parkin-mediated mitophagy is dependent on VDAC1 and p62/SQSTM1. Nat. Cell Biol. 12:2 (2010), 119–131, 10.1038/ncb2012.
30. [30] Shirihai, O.S., Song, M., Dorn, G.W. 2nd, How mitochondrial dynamism orchestrates mitophagy. Circ. Res. 116:11 (2015), 1835–1849, 10.1161/CIRCRESAHA.116.306374.
31. [31] Lee, J.Y., Nagano, Y., Taylor, J.P., Lim, K.L., Yao, T.P., Disease-causing mutations in parkin impair mitochondrial ubiquitination, aggregation, and HDAC6-dependent mitophagy. J. Cell. Biol. 189:4 (2010), 671–679, 10.1083/jcb.201001039.
32. [32] Liesa, M., Palacín, M., Zorzano, A., Mitochondrial dynamics in mammalian health and disease. Physiol. Rev. 89:3 (2009), 799–845, 10.1152/physrev.00030.2008.
33. [33] Kytövuori, L., Lipponen, J., Rusanen, H., Komulainen, T., Martikainen, M.H., Majamaa, K., A novel mutation m.8561C>G in MT-ATP6/8 causing a mitochondrial syndrome with ataxia, peripheral neuropathy, diabetes mellitus, and hypergonadotropic hypogonadism. J. Neurol. 263:11 (2016), 2188–2195, 10.1007/s00415-016-8249-2.
34. [34] Hoeks, J., Hesselink, M.K., Russell, A.P., Mensink, M., Saris, W.H., Mensink, R.P., Schrauwen, P., Peroxisome proliferator-activated receptor-gamma coactivator-1 and insulin resistance: acute effect of fatty acids. Diabetologia 49:10 (2006), 2419–2426, 10.1007/s00125-006-0369-2.
35. [35] Maechler, P., Wollheim, C.B., Mitochondrial function in normal and diabetic beta-cells. Nature 414:6865 (2001), 807–812, 10.1038/414807a.
36. [36] Diaz-Morales, N., Rovira-Llopis, S., Bañuls, C., Escribano-Lopez, I., de Marañon, A.M., Lopez-Domenech, S., Orden, S., Roldan-Torres, I., Alvarez, A., Veses, S., Jover, A., Rocha, M., Hernandez-Mijares, A., Victor, V.M., Are Mitochondrial Fusion and Fission Impaired in Leukocytes of Type 2 Diabetic Patients?. Antioxid. Redox Signal. 25:2 (2016), 108–115, 10.1089/ars.2016.6707.
37. [37] Hernandez-Mijares, A., Rocha, M., Apostolova, N., Borras, C., Jover, A., Bañuls, C., Sola, E., Victor, V.M., Mitochondrial complex I impairment in leukocytes from type 2 diabetic patients. Free Radic. Biol. Med. 50:10 (2011), 1215–1221, 10.1016/j.freeradbiomed.2011.01.019.
38. [38] Lowell, B.B., Shulman, G.I., Mitochondrial dysfunction and type 2 diabetes. Science 307:5708 (2005), 384–387, 10.1126/science.1104343.
39. [39] Rovira-Llopis, S., Díaz-Morales, N., Bañuls, C., Blas-García, A., Polo, M., López-Domenech, S., Jover, A., Rocha, M., Hernández-Mijares, A., Víctor, V.M., Is Autophagy Altered in the Leukocytes of Type 2 Diabetic Patients?. Antioxid. Redox Signal. 23:13 (2015), 1050–1056, 10.1089/ars.2015.6447.
40. [40] Kelley, D.E., He, J., Menshikova, E.V., Ritov, V.B., Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes. Diabetes 51:10 (2002), 2944–2950, 10.2337/diabetes.51.10.2944.
41. [41] Mootha, V.K., Lindgren, C.M., Eriksson, K.F., Subramanian, A., Sihag, S., Lehar, J., Puigserver, P., Carlsson, E., Ridderstråle, M., Laurila, E., Houstis, N., Daly, M.J., Patterson, N., Mesirov, J.P., Golub, T.R., Tamayo, P., Spiegelman, B., Lander, E.S., Hirschhorn, J.N., Altshuler, D., Groop, L.C., PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat. Genet. 34:3 (2003), 267–273, 10.1038/ng1180.
42. [42] Heinonen, S., Buzkova, J., Muniandy, M., Kaksonen, R., Ollikainen, M., Ismail, K., Hakkarainen, A., Lundbom, J., Lundbom, N., Vuolteenaho, K., Moilanen, E., Kaprio, J., Rissanen, A., Suomalainen, A., Pietiläinen, K.H., Impaired mitochondrial biogenesis in adipose tissue in acquired obesity. Diabetes 64:9 (2015), 3135–3145, 10.2337/db14-1937.
43. [43] Apostolova, N., Victor, V.M., Molecular strategies for targeting antioxidants to mitochondria: therapeutic implications. Antioxid. Redox Signal. 22:8 (2015), 686–729, 10.1089/ars.2014.5952.
44. [44] Escribano-Lopez, I., Diaz-Morales, N., Rovira-Llopis, S., de Marañon, A.M., Orden, S., Alvarez, A., Bañuls, C., Rocha, M., Murphy, M.P., Hernandez-Mijares, A., Victor, V.M., The mitochondria-targeted antioxidant MitoQ modulates oxidative stress, inflammation and leukocyte-endothelium interactions in leukocytes isolated from type 2 diabetic patients. Redox Biol. 10 (2016), 200–205, 10.1016/j.redox.2016.10.017.
45. [45] Larson-Meyer, D.E., Heilbronn, L.K., Redman, L.M., Newcomer, B.R., Frisard, M.I., Anton, S., Smith, S.R., Alfonso, A., Ravussin, E., Effect of calorie restriction with or without exercise on insulin sensitivity, beta-cell function, fat cell size, and ectopic lipid in overweight subjects. Diabetes Care 29:6 (2006), 1337–1344, 10.2337/dc05-2565.
46. [46] Rimbert, V., Boirie, Y., Bedu, M., Hocquette, J.F., Ritz, P., Morio, B., Muscle fat oxidative capacity is not impaired by age but by physical inactivity: association with insulin sensitivity. FASEB J. 18:6 (2004), 737–739, 10.1096/fj.03-1104fje.
47. [47] Toledo, F.G., Menshikova, E.V., Ritov, V.B., Azuma, K., Radikova, Z., DeLany, J., Kelley, D.E., Effects of physical activity and weight loss on skeletal muscle mitochondria and relationship with glucose control in type 2 diabetes. Diabetes 56:8 (2007), 2142–2147, 10.2337/db07-0141.
48. [48] Li, A., Zhang, S., Li, J., Liu, K., Huang, F., Liu, B., Metformin and resveratrol inhibit Drp1-mediated mitochondrial fission and prevent ER stress-associated NLRP3 inflammasome activation in the adipose tissue of diabetic mice. Mol. Cell Endocrinol. 434 (2016), 36–47, 10.1016/j.mce.2016.06.008.
49. [49] Hou, Y., Li, S., Wu, M., Wei, J., Ren, Y., Du, C., Wu, H., Han, C., Duan, H., Shi, Y., Mitochondria-targeted peptide SS-31 attenuates renal injury via an antioxidant effect in diabetic nephropathy. Am. J. Physiol. Renal Physiol. 310:6 (2016), F547–F559, 10.1152/ajprenal.00574.2014.
50. [50] Byrne, H., Caulfield, B., De Vito, G., Effects of Self-directed Exercise Programmes on Individuals with Type 2 Diabetes Mellitus: A Systematic Review Evaluating Their Effect on HbA1c and Other Metabolic Outcomes, Physical Characteristics, Cardiorespiratory Fitness and Functional Outcomes. Sports Med., 2016, 10.1007/s40279-016-0593-y.
51. [51] Sathananthan, M., Shah, M., Edens, K.L., Grothe, K.B., Piccinini, F., Farrugia, L.P., Micheletto, F., Man, C.D., Cobelli, C., Rizza, R.A., Camilleri, M., Vella, A., Six and 12 Weeks of Caloric Restriction Increases β Cell Function and Lowers Fasting and Postprandial Glucose Concentrations in People with Type 2 Diabetes. J. Nutr. 145:9 (2015), 2046–2051, 10.3945/jn.115.210617.
52. [52] Lo, M.C., Chen, M.H., Lee, W.S., Lu, C.I., Chang, C.R., Kao, S.H., Lee, H.M., Nε-(carboxymethyl) lysine-induced mitochondrial fission and mitophagy cause decreased insulin secretion from β-cells. Am. J. Physiol. Endocrinol. Metab. 309:10 (2015), E829–E839, 10.1152/ajpendo.00151.2015.
53. [53] Reinhardt, F., Schultz, J., Waterstradt, R., Baltrusch, S., Drp1 guarding of the mitochondrial network is important for glucose-stimulated insulin secretion in pancreatic beta cells. Biochem. Biophys. Res. Commun. 474:4 (2016 10), 646–651, 10.1016/j.bbrc.2016.04.142.
54. [54] Cerqueira, F.M., Chausse, B., Baranovski, B.M., Liesa, M., Lewis, E.C., Shirihai, O.S., Kowaltowski, A.J., Diluted serum from calorie-restricted animals promotes mitochondrial β-cell adaptations and protect against glucolipotoxicity. FEBS J. 283:5 (2016), 822–833, 10.1111/febs.13632.
55. [55] Molina, A.J., Wikstrom, J.D., Stiles, L., Las, G., Mohamed, H., Elorza, A., Walzer, G., Twig, G., Katz, S., Corkey, B.E., Shirihai, O.S., Mitochondrial networking protects beta-cells from nutrient-induced apoptosis. Diabetes 58:10 (2009), 2303–2315, 10.2337/db07-1781.
56. [56] Cang, X., Wang, X., Liu, P., Wu, X., Yan, J., Chen, J., Wu, G., Jin, Y., Xu, F., Su, J., Wan, C., Wang, X., PINK1 alleviates palmitate induced insulin resistance in HepG2 cells by suppressing ROS mediated MAPK pathways. Biochem. Biophys. Res. Commun. 478:1 (2016), 431–438, 10.1016/j.bbrc.2016.07.004.
57. [57] Zorzano, A., Liesa, M., Palacín, M., Mitochondrial dynamics as a bridge between mitochondrial dysfunction and insulin resistance. Arch. Physiol. Biochem. 115:1 (2009), 1–12, 10.1080/1381345080267633.
58. [58] Fealy, C.E., Mulya, A., Lai, N., Kirwan, J.P., Exercise training decreases activation of the mitochondrial fission protein dynamin-related protein-1 in insulin-resistant human skeletal muscle. J. Appl. Physiol. 117:3 (2014), 239–245, 10.1152/japplphysiol.01064.2013.
59. [59] Veeranki, S., Givvimani, S., Kundu, S., Metreveli, N., Pushpakumar, S., Tyagi, S.C., Moderate intensity exercise prevents diabetic cardiomyopathy associated contractile dysfunction through restoration of mitochondrial function and connexin 43 levels in db/db mice. J. Mol. Cell. Cardiol. 92 (2016), 163–173, 10.1016/j.yjmcc.2016.01.023.
60. [60] Arruda, A.P., Pers, B.M., Parlakgül, G., Güney, E., Inouye, K., Hotamisligil, G.S., Chronic enrichment of hepatic endoplasmic reticulum-mitochondria contact leads to mitochondrial dysfunction in obesity. Nat. Med. 20:12 (2014), 1427–1435, 10.1038/nm.3735.
61. [61] Rovira-Llopis, S., Bañuls, C., Apostolova, N., Morillas, C., Hernandez-Mijares, A., Rocha, M., Victor, V.M., Is glycemic control modulating endoplasmic reticulum stress in leukocytes of type 2 diabetic patients?. Antioxid. Redox Signal. 21:12 (2014), 1759–1765, 10.1089/ars.2014.6030.
62. [62] Paltauf-Doburzynska, J., Malli, R., Graier, W.F., Hyperglycemic conditions affect shape and Ca2+ homeostasis of mitochondria in endothelial cells. J. Cardiovasc. Pharmacol. 44:4 (2004), 423–436.
63. [63] Yu, T., Robotham, J.L., Yoon, Y., Increased production of reactive oxygen species in hyperglycemic conditions requires dynamic change of mitochondrial morphology. Proc. Natl. Acad. Sci. USA 103:8 (2006), 2653–2658, 10.1073/pnas.0511154103.
64. [64] Vanhorebeek, I., De Vos, R., Mesotten, D., Wouters, P.J., De Wolf-Peeters, C., Van, den Berghe, G., Protection of hepatocyte mitochondrial ultrastructure and function by strict blood glucose control with insulin in critically ill patients. Lancet 365:9453 (2005), 53–59, 10.1016/S0140-6736(04)17665-4.
65. [65] Gerber, P.A., Rutter, G.A., The Role of Oxidative Stress and Hypoxia in Pancreatic Beta-Cell Dysfunction in Diabetes Mellitus. Antioxid. Redox Signal., 2016, 10.1089/ars.2016.6755.
66. [66] Montaigne, D., Marechal, X., Coisne, A., Debry, N., Modine, T., Fayad, G., Potelle, C., El Arid, J.M., Mouton, S., Sebti, Y., Duez, H., Preau, S., Remy-Jouet, I., Zerimech, F., Koussa, M., Richard, V., Neviere, R., Edme, J.L., Lefebvre, P., Staels, B., Myocardial contractile dysfunction is associated with impaired mitochondrial function and dynamics in type 2 diabetic but not in obese patients. Circulation 130:7 (2014), 554–564, 10.1161/CIRCULATIONAHA.113.008476.
67. [67] Schultz, J., Waterstradt, R., Kantowski, T., Rickmann, A., Reinhardt, F., Sharoyko, V., Mulder, H., Tiedge, M., Baltrusch, S., Precise expression of Fis1 is important for glucose responsiveness of beta cells. J. Endocrinol. 230:1 (2016), 81–91, 10.1530/JOE-16-0111.
68. [68] Jheng, H.F., Huang, S.H., Kuo, H.M., Hughes, M.W., Tsai, Y.S., Molecular insight and pharmacological approaches targeting mitochondrial dynamics in skeletal muscle during obesity. Ann. N. Y. Acad. Sci. 1350 (2015), 82–94, 10.1111/nyas.12863.
69. [69] Cassidy-Stone, A., Chipuk, J.E., Ingerman, E., Song, C., Yoo, C., Kuwana, T., Kurth, M.J., Shaw, J.T., Hinshaw, J.E., Green, D.R., Nunnari, J., Chemical inhibition of the mitochondrial division dynamin reveals its role in Bax/Bak-dependent mitochondrial outer membrane permeabilization. Dev. Cell. 14:2 (2008), 193–204, 10.1016/j.devcel.2007.11.019.
70. [70] Ong, S.B., Subrayan, S., Lim, S.Y., Yellon, D.M., Davidson, S.M., Hausenloy, D.J., Inhibiting mitochondrial fission protects the heart against ischemia/reperfusion injury. Circulation 121:18 (2010), 2012–2022, 10.1161/CIRCULATIONAHA.109.906610.
71. [71] Jheng, H.F., Tsai, P.J., Guo, S.M., Kuo, L.H., Chang, C.S., Su, I.J., Chang, C.R., Tsai, Y.S., Mitochondrial fission contributes to mitochondrial dysfunction and insulin resistance in skeletal muscle. Mol. Cell Biol. 32:2 (2012), 309–319, 10.1128/MCB.05603-11.
72. [72] Wang Q, Zhang, M., Torres, G., Wu, S., Ouyang, C., Xie, Z., Zou, M.H., Metformin Suppresses Diabetes-Accelerated Atherosclerosis via the Inhibition of Drp1-Mediated Mitochondrial Fission. Diabetes, 2016, 10.2337/db16-0915.
73. [73] Kim, B., Kim, J.S., Yoon, Y., Santiago, M.C., Brown, M.D., Park, J.Y., Inhibition of Drp1-dependent mitochondrial division impairs myogenic differentiation. Am. J. Physiol. Regul. Integr. Comp. Physiol. 305:8 (2013), R927–R938, 10.1152/ajpregu.00502.2012.
74. [74] Salabei, J.K., Hill, B.G., Mitochondrial fission induced by platelet-derived growth factor regulates vascular smooth muscle cell bioenergetics and cell proliferation. Redox Biol. 1 (2013), 542–551, 10.1016/j.redox.2013.10.011.
75. [75] Wang, J., Hansen, K., Edwards, R., Van Houten, B., Qian, W., Mitochondrial division inhibitor 1 (mdivi-1) enhances death receptor-mediated apoptosis in human ovarian cancer cells. Biochem. Biophys. Res. Commun. 456:1 (2015), 7–12, 10.1016/j.bbrc.2014.11.010.
76. [76] Macia, E., Ehrlich, M., Massol, R., Boucrot, E., Brunner, C., Kirchhausen, T., Dynasore, a cell-permeable inhibitor of dynamin. Dev. Cell. 10:6 (2006), 839–850, 10.1016/j.devcel.2006.04.002.
77. [77] Gao, D., Zhang, L., Dhillon, R., Hong, T.T., Shaw, R.M., Zhu, J., Dynasore protects mitochondria and improves cardiac lusitropy in Langendorff perfused mouse heart. PLoS One, 8(4), 2013, e60967, 10.1371/journal.pone.0060967.
78. [78] Qi, X., Qvit, N., Su, Y.C., Mochly-Rosen, D., A novel Drp1 inhibitor diminishes aberrant mitochondrial fission and neurotoxicity. J. Cell Sci. 126:Pt 3 (2013), 789–802, 10.1242/jcs.114439.
79. [79] Guo, X., Sesaki, H., Qi, X., Drp1 stabilizes p53 on the mitochondria to trigger necrosis under oxidative stress conditions in vitro and in vivo. Biochem. J. 461:1 (2014), 137–146, 10.1042/BJ20131438.
80. [80] Su, Y.C., Qi, X., Inhibition of excessive mitochondrial fission reduced aberrant autophagy and neuronal damage caused by LRRK2 G2019S mutation. Hum. Mol. Genet. 22:22 (2013), 4545–4561, 10.1093/hmg/ddt301.
81. [81] Filichia, E., Hoffer, B., Qi, X., Luo, Y., Inhibition of Drp1 mitochondrial translocation provides neural protection in dopaminergic system in a Parkinson's disease model induced by MPTP. Sci. Rep., 6, 2016, 32656, 10.1038/srep32656.
82. [82] Zhan, L., Cao, H., Wang, G., Lyu, Y., Sun, X., An, J., Wu, Z., Huang, Q., Liu, B., Xing, J., Drp1-mediated mitochondrial fission promotes cell proliferation through crosstalk of p53 and NF-κB pathways in hepatocellular carcinoma. Oncotarget, 2016, 10.18632/oncotarget.11339.
83. [83] Liu, J., Mu, C., Yue, W., Li, J., Ma, B., Zhao, L., Liu, L., Chen, Q., Yan, C., Liu, H., Hao, X., Zhu, Y., A diterpenoid derivate compound targets selenocysteine of thioredoxin reductases and induces Bax/Bak-independent apoptosis. Free Radic. Biol. Med. 63 (2013), 485–494, 10.1016/j.freeradbiomed.2013.05.038.
84. [84] Yue, W., Chen, Z., Liu, H., Yan, C., Chen, M., Feng, D., Yan, C., Wu, H., Du, L., Wang, Y., Liu, J., Huang, X., Xia, L., Liu, L., Wang, X., Jin, H., Wang, J., Song, Z., Hao, X., Chen, Q., A small natural molecule promotes mitochondrial fusion through inhibition of the deubiquitinase USP30. Cell Res. 24:4 (2014), 482–496, 10.1038/cr.2014.20.
85. [85] Jimenez, R.E., Kubli, D.A., Gustafsson, Å.B., Autophagy and mitophagy in the myocardium: therapeutic potential and concerns. Br. J. Pharmacol. 171:8 (2014), 1907–1916, 10.1111/bph.12477.
86. [86] Higgins, G.C., Coughlan, M.T., Mitochondrial dysfunction and mitophagy: the beginning and end to diabetic nephropathy?. Br. J. Pharmacol. 171:8 (2014), 1917–1942, 10.1111/bph.12503.
87. [87] Zhang, T., Xue, L., Li, L., Tang, C., Wan, Z., Wang, R., Tan, J., Tan, Y., Han, H., Tian, R., Billiar, T.R., Tao, W.A., Zhang, Z., BNIP Suppresses PINK1 Proteolytic Cleavage to Promote Mitophagy. J. Biol. Chem., 2016, 10.1074/jbc.M116.733410.
88. [88] Hartleben, B., Gödel, M., Meyer-Schwesinger, C., Liu, S., Ulrich, T., Köbler, S., Wiech, T., Grahammer, F., Arnold, S.J., Lindenmeyer, M.T., Cohen, C.D., Pavenstädt, H., Kerjaschki, D., Mizushima, N., Shaw, A.S., Walz, G., Huber, T.B., Autophagy influences glomerular disease susceptibility and maintains podocyte homeostasis in aging mice. J. Clin. Invest. 120:4 (2010), 1084–1096, 10.1172/JCI39492.
89. [89] Mori, H., Inoki, K., Masutani, K., Wakabayashi, Y., Komai, K., Nakagawa, R., Guan, K.L., Yoshimura, A., The mTOR pathway is highly activated in diabetic nephropathy and rapamycin has a strong therapeutic potential. Biochem. Biophys. Res. Commun. 384:4 (2009), 471–475, 10.1016/j.bbrc.2009.04.136.
90. [90] Sakaguchi, M., Isono, M., Isshiki, K., Sugimoto, T., Koya, D., Kashiwagi, A., Inhibition of mTOR signaling with rapamycin attenuates renal hypertrophy in the early diabetic mice. Biochem. Biophys. Res. Commun. 340:1 (2006), 296–301, 10.1016/j.bbrc.2005.12.012.
91. [91] Yang, Y., Wang, J., Qin, L., Shou, Z., Zhao, J., Wang, H., Chen, Y., Chen, J., Rapamycin prevents early steps of the development of diabetic nephropathy in rats. Am. J. Nephrol. 27:5 (2007), 495–502, 10.1159/000106782.
92. [92] Huang, C., Zhang, Y., Kelly, D.J., Tan, C.Y., Gill, A., Cheng, D., Braet, Park, J.S., Sue, C.M., Pollock, C.A., Chen, X.M., Thioredoxin interacting protein (TXNIP) regulates tubular autophagy and mitophagy in diabetic nephropathy through the mTOR signaling pathway. Sci. Rep., 6, 2016, 29196, 10.1038/srep29196.